Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q1 EPS of ($0.38), $0.10 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $21.62 million versus the consensus estimate of $24.77 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.